124 related articles for article (PubMed ID: 23037605)
1. [Diagnostic imaging of high-grade astrocytoma: heterogeneity of clinical manifestation, image characteristics, and histopathological findings].
Okajima K; Ohta Y
Brain Nerve; 2012 Oct; 64(10):1151-7. PubMed ID: 23037605
[TBL] [Abstract][Full Text] [Related]
2. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.
Leenstra S; Troost D; Westerveld A; Bosch DA; Hulsebos TJ
Cancer Res; 1992 Mar; 52(6):1568-72. PubMed ID: 1311634
[TBL] [Abstract][Full Text] [Related]
4. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
5. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
7. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.
Faehndrich J; Weidauer S; Pilatus U; Oszvald A; Zanella FE; Hattingen E
Clin Neuroradiol; 2011 Sep; 21(3):123-39. PubMed ID: 21538040
[TBL] [Abstract][Full Text] [Related]
8. Revisiting anaplastic astrocytomas II: further characterization of an expansive growth pattern with visually enhanced diffusion tensor imaging.
Guan X; Lai S; Lackey J; Shi J; Techavipoo U; Moulding HD; Flanders AE; Andrews DW
J Magn Reson Imaging; 2008 Dec; 28(6):1322-36. PubMed ID: 19025901
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
[TBL] [Abstract][Full Text] [Related]
10. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
[TBL] [Abstract][Full Text] [Related]
11. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
12. MRI of high-grade astrocytic tumors: early appearance and evolution.
Okamoto K; Ito J; Takahashi N; Ishikawa K; Furusawa T; Tokiguchi S; Sakai K
Neuroradiology; 2002 May; 44(5):395-402. PubMed ID: 12012123
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
14. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
Perry A; Aldape KD; George DH; Burger PC
Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
[TBL] [Abstract][Full Text] [Related]
15. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD
Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088
[TBL] [Abstract][Full Text] [Related]
16. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers.
Li J; Zhuang Z; Okamoto H; Vortmeyer AO; Park DM; Furuta M; Lee YS; Oldfield EH; Zeng W; Weil RJ
Neurology; 2006 Mar; 66(5):733-6. PubMed ID: 16534112
[TBL] [Abstract][Full Text] [Related]
18. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
19. Brain astrocytomas: biopsy, then irradiation.
Lunsford LD; Somaza S; Kondziolka D; Flickinger JC
Clin Neurosurg; 1995; 42():464-79. PubMed ID: 8846611
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.
Young BD; Levine JM; Porter BF; Chen-Allen AV; Rossmeisl JH; Platt SR; Kent M; Fosgate GT; Schatzberg SJ
Vet Radiol Ultrasound; 2011; 52(2):132-41. PubMed ID: 21388463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
